dc.contributor.author | Mystakidou, K | en |
dc.contributor.author | Katsouda, E | en |
dc.contributor.author | Linou, A | en |
dc.contributor.author | Parpa, E | en |
dc.contributor.author | Kouloulias, V | en |
dc.contributor.author | Nikolaou, V | en |
dc.contributor.author | Vlahos, L | en |
dc.date.accessioned | 2014-03-01T01:55:11Z | |
dc.date.available | 2014-03-01T01:55:11Z | |
dc.date.issued | 2006 | en |
dc.identifier.uri | https://dspace.lib.ntua.gr/xmlui/handle/123456789/27635 | |
dc.subject | Adverse Effect | en |
dc.subject | Cancer Patient | en |
dc.subject | Radiation Therapy | en |
dc.subject | Statistical Significance | en |
dc.title | Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas | en |
heal.type | journalArticle | en |
heal.identifier.primary | 10.1385/MO:23:2:251 | en |
heal.identifier.secondary | http://dx.doi.org/10.1385/MO:23:2:251 | en |
heal.publicationDate | 2006 | en |
heal.abstract | Aim A prospective randomized open label study was carried out to evaluate the efficacy and effectiveness of prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy. Patients and Methods The study sample consisted of 288 cancer patients randomly allocated (3∶4 ratio) into two treatment groups: 120 patients received prophylactic antiemetic treatment with tropisetro and 168 patients received rescue tropisetron. To determine the efficacy | en |
heal.journalName | Medical Oncology | en |
dc.identifier.doi | 10.1385/MO:23:2:251 | en |
Αρχεία | Μέγεθος | Μορφότυπο | Προβολή |
---|---|---|---|
Δεν υπάρχουν αρχεία που σχετίζονται με αυτό το τεκμήριο. |